| Literature DB >> 24956085 |
Li Buay Koh1, Mohammad Mirazul Islam2, Debbie Mitra3, Christopher W Noel4, Kimberley Merrett5, Silvia Odorcic6, Per Fagerholm7, William Bruce Jackson8, Bo Liedberg9, Jaywant Phopase10, May Griffith11.
Abstract
A bi-functional epoxy-based cross-linker, 1,4-Butanediol diglycidyl ether (BDDGE), was investigated in the fabrication of collagen based corneal substitutes. Two synthetic strategies were explored in the preparation of the cross-linked collagen scaffolds. The lysine residues of Type 1 porcine collagen were directly cross-linked using l,4-Butanediol diglycidyl ether (BDDGE) under basic conditions at pH 11. Alternatively, under conventional methodology, using both BDDGE and 1-Ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS) as cross-linkers, hydrogels were fabricated under acidic conditions. In this latter strategy, Cu(BF4)2·XH2O was used to catalyze the formation of secondary amine bonds. To date, we have demonstrated that both methods of chemical cross-linking improved the elasticity and tensile strength of the collagen implants. Differential scanning calorimetry and biocompatibility studies indicate comparable, and in some cases, enhanced properties compared to that of the EDC/NHS controls. In vitro studies showed that human corneal epithelial cells and neuronal progenitor cell lines proliferated on these hydrogels. In addition, improvement of cell proliferation on the surfaces of the materials was observed when neurite promoting laminin epitope, IKVAV, and adhesion peptide, YIGSR, were incorporated. However, the elasticity decreased with peptide incorporation and will require further optimization. Nevertheless, we have shown that epoxy cross-linkers should be further explored in the fabrication of collagen-based hydrogels, as alternatives to or in conjunction with carbodiimide cross-linkers.Entities:
Year: 2013 PMID: 24956085 PMCID: PMC4030907 DOI: 10.3390/jfb4030162
Source DB: PubMed Journal: J Funct Biomater ISSN: 2079-4983
Scheme 1Scheme illustrating the predicted collagen cross-linking using BDDGE and EDC/NHS coupling.
Properties of l,4-Butanediol diglycidyl ether (BDDGE) cross-linked with 10% w/w porcine Type I collagen hydrogels content. Data were run in triplicate (n = 3) and expressed as mean (relative standard error %) and repeated for three independent experiments.
| Properties | Human cornea | Type 1 porcine collagen | ||
|---|---|---|---|---|
| Control EDC/NHS | BDDGE | BDDGE-EDC/NHS | ||
|
| - | 5 | 11 | 5 |
|
| ||||
|
| 1.37–1.38 [ | 1.35 | 1.35 | 1.35 |
|
| >85 [ | 82.1 (2.1%) | 86 (1.3%) | 86 (1.3%) |
|
| 6.0-8.0 [ | 2.8 (10.3%) | 1.9 (6%) | 0.4 (43%) |
|
| ||||
|
| 3.8 [ | 0.19 (3%) | 0.21 (2.7%) | 0.44 (1.3%) * |
|
| - | 23.13 (2%) | 14.02 (0.7%) * | 147 (15.7%) * |
|
| 3.0–13.0 [ | 1.88 (6.4%) | 2.86 (1.6%) * | 2.69 (2.8%) * |
|
| ||||
|
| 65.1 [ | 46.8 | 52.9 | 53.6 |
|
| 80 [ | 91 | 92 | 92 |
* Denotes significant difference (p < 0.05) when compared against the EDC/NHS control.
Figure 1Degradation profile of 10% w/w BDDGE cross-linked hydrogels after exposure to collagenase and compared to EDC/NHS cross-linked hydrogels.
Figure 2Femtosecond laser-assisted tophat cuts of the BDDGE cross-linked hydrogels that were cross-linked (a) at pH 11; and (b) at pH 5, with subsequent cross-linking with EDC/NHS.
Properties of BDDGE cross-linked, 18% w/w porcine Type I collagen hydrogels (n = 3 samples per group). Data are expressed as mean (relative standard error %) and repeated for three independent experiments.
| Properties | Human cornea | Type 1 porcine collagen | ||||
|---|---|---|---|---|---|---|
| Control EDC/NHS | BDDGE | BDDGE-EDC/NHS | YIGSR | IKVAV | ||
|
| - | 5 | 11 | 5 | 5 | 5 |
|
| ||||||
|
| >85 [ | 85.67 (0.8%) | 81.07 (0.7%) | 84.17 (0.8%) | 84.03 (1.3%) | 82.10 (0.8%) |
|
| ||||||
|
| 3.8 [ | 0.12 (14.4%) | 0.10 (17.3%) | 0.16 (7.2%) | 0.13 (4.4%) | 0.17 (44%) |
|
| - | 44.52 (24.4%) | 16.63 (6.2%) * | 120.48 (9.3%) * | 23.81 (5.9%) | 44.76 (2.6%) |
|
| 3.0-13.0 [ | 0.64 (39.6%) | 1.21 (15.7%) * | 0.21 (8.2%) * | 0.98 (1.7%) | 0.55 (46%) |
|
| ||||||
|
| 65.1 [ | 49.1 | 65.9 | 49.5 | 47.2 | 55.0 & 64.4 |
* Denotes significant difference (p < 0.05) when compared against the EDC/NHS benchmark.
Figure 3Visualization of biotin-IKVAV peptides incorporated into BDDGE-EDC/NHS collagen hydrogel, with FITC-streptavidin. The inset shows the EDC/NHS control hydrogel without peptide. Scale bar = 100 μm.
Figure 4Degradation profile of 18% w/w BDDGE cross-linked hydrogels after exposure to collagenase and compared to EDC/NHS cross-linked hydrogels.
Figure 5Confocal laser scanning microscope (CLSM) showing the biocompatibility of the BDDGE cross-linked hydrogels with negligible amount of dead HCECs from the live/dead stain at day one and four respectively. Green and red fluorescence indicated live and dead HCECs, respectively. Scale bar = 100 μm.
Figure 6Proliferation rates of (A) human corneal epithelial cells; and (B) neuronal progenitor cells (NDC cell line) on different hydrogels at days one, four and seven. Samples were run in triplicate (n = 3) and results were expressed as means, and repeated for three independent experiments. * Statistical significance by ANOVA (p < 0.05).